Lone Skov
Clinical trials sponsored by Lone Skov, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Can a common arthritis drug tame stubborn hand eczema? Results expected Sep 2026 (estimated)
- Can a skin cream bring back color to faces with vitiligo? Results expected Apr 2027 (estimated)
-
Can a skin cream bring back color to faces with vitiligo?
Disease control OngoingResearchers are testing a cream called delgocitinib on facial vitiligo, a condition where skin loses its color in patches. Twelve adults with non-segmental vitiligo on the face will apply the cream twice daily for 24 weeks. The trial measures changes in the size and severity of w…
Phase 2 • Sponsor: Lone Skov • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Can a common arthritis drug tame stubborn hand eczema?
Disease control OngoingThis study looks at how well methotrexate, a drug often used for arthritis, works for people with hand eczema. Researchers will track 50 patients to see if their skin improves and how their quality of life changes. The goal is to find better ways to manage this chronic skin condi…
Sponsor: Lone Skov • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC